vs
Side-by-side financial comparison of Albemarle Corporation (ALB) and Organon & Co. (OGN). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $1.4B, roughly 1.1× Albemarle Corporation). Organon & Co. runs the higher net margin — -13.6% vs -29.0%, a 15.4% gap on every dollar of revenue. On growth, Albemarle Corporation posted the faster year-over-year revenue change (15.9% vs -5.3%). Albemarle Corporation produced more free cash flow last quarter ($233.1M vs $96.0M). Over the past eight quarters, Albemarle Corporation's revenue compounded faster (2.4% CAGR vs -3.6%).
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers...
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
ALB vs OGN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.4B | $1.5B |
| Net Profit | $-414.2M | $-205.0M |
| Gross Margin | 13.9% | 49.2% |
| Operating Margin | -15.2% | -9.8% |
| Net Margin | -29.0% | -13.6% |
| Revenue YoY | 15.9% | -5.3% |
| Net Profit YoY | -650.1% | -288.1% |
| EPS (diluted) | $-3.88 | $-0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.4B | $1.5B | ||
| Q3 25 | $1.3B | $1.6B | ||
| Q2 25 | $1.3B | $1.6B | ||
| Q1 25 | $1.1B | $1.5B | ||
| Q4 24 | $1.2B | $1.6B | ||
| Q3 24 | $1.4B | $1.6B | ||
| Q2 24 | $1.4B | $1.6B | ||
| Q1 24 | $1.4B | $1.6B |
| Q4 25 | $-414.2M | $-205.0M | ||
| Q3 25 | $-160.7M | $160.0M | ||
| Q2 25 | $22.9M | $145.0M | ||
| Q1 25 | $41.3M | $87.0M | ||
| Q4 24 | $75.3M | $109.0M | ||
| Q3 24 | $-1.1B | $359.0M | ||
| Q2 24 | $-188.2M | $195.0M | ||
| Q1 24 | $2.4M | $201.0M |
| Q4 25 | 13.9% | 49.2% | ||
| Q3 25 | 9.0% | 53.5% | ||
| Q2 25 | 14.8% | 54.8% | ||
| Q1 25 | 14.5% | 55.6% | ||
| Q4 24 | 11.2% | 56.3% | ||
| Q3 24 | -7.7% | 58.3% | ||
| Q2 24 | -0.7% | 58.4% | ||
| Q1 24 | 2.9% | 59.0% |
| Q4 25 | -15.2% | -9.8% | ||
| Q3 25 | -16.6% | 15.2% | ||
| Q2 25 | 3.6% | 14.4% | ||
| Q1 25 | 1.8% | 6.7% | ||
| Q4 24 | 0.4% | 8.1% | ||
| Q3 24 | -81.9% | 13.1% | ||
| Q2 24 | -34.4% | 14.6% | ||
| Q1 24 | -13.2% | 14.5% |
| Q4 25 | -29.0% | -13.6% | ||
| Q3 25 | -12.3% | 10.0% | ||
| Q2 25 | 1.7% | 9.1% | ||
| Q1 25 | 3.8% | 5.8% | ||
| Q4 24 | 6.1% | 6.8% | ||
| Q3 24 | -78.9% | 22.7% | ||
| Q2 24 | -13.2% | 12.1% | ||
| Q1 24 | 0.2% | 12.4% |
| Q4 25 | $-3.88 | $-0.78 | ||
| Q3 25 | $-1.72 | $0.61 | ||
| Q2 25 | $-0.16 | $0.56 | ||
| Q1 25 | $0.00 | $0.33 | ||
| Q4 24 | $0.29 | $0.42 | ||
| Q3 24 | $-9.45 | $1.38 | ||
| Q2 24 | $-1.96 | $0.75 | ||
| Q1 24 | $-0.08 | $0.78 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $574.0M |
| Total DebtLower is stronger | $3.2B | $8.6B |
| Stockholders' EquityBook value | $9.5B | $752.0M |
| Total Assets | $16.4B | $12.9B |
| Debt / EquityLower = less leverage | 0.33× | 11.49× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $574.0M | ||
| Q3 25 | $1.9B | $672.0M | ||
| Q2 25 | $1.8B | $599.0M | ||
| Q1 25 | $1.5B | $547.0M | ||
| Q4 24 | $1.2B | $675.0M | ||
| Q3 24 | $1.7B | $763.0M | ||
| Q2 24 | $1.8B | $704.0M | ||
| Q1 24 | $2.1B | $575.0M |
| Q4 25 | $3.2B | $8.6B | ||
| Q3 25 | $3.6B | $8.8B | ||
| Q2 25 | $3.6B | $8.9B | ||
| Q1 25 | $3.5B | $9.0B | ||
| Q4 24 | $3.5B | $8.9B | ||
| Q3 24 | $3.6B | $8.7B | ||
| Q2 24 | $3.5B | $8.7B | ||
| Q1 24 | $3.5B | $8.7B |
| Q4 25 | $9.5B | $752.0M | ||
| Q3 25 | $10.0B | $906.0M | ||
| Q2 25 | $10.2B | $733.0M | ||
| Q1 25 | $10.0B | $542.0M | ||
| Q4 24 | $10.0B | $472.0M | ||
| Q3 24 | $10.2B | $493.0M | ||
| Q2 24 | $11.2B | $144.0M | ||
| Q1 24 | $11.5B | $48.0M |
| Q4 25 | $16.4B | $12.9B | ||
| Q3 25 | $17.1B | $13.6B | ||
| Q2 25 | $17.3B | $13.5B | ||
| Q1 25 | $17.0B | $13.2B | ||
| Q4 24 | $16.6B | $13.1B | ||
| Q3 24 | $17.5B | $12.8B | ||
| Q2 24 | $18.4B | $12.2B | ||
| Q1 24 | $19.0B | $11.9B |
| Q4 25 | 0.33× | 11.49× | ||
| Q3 25 | 0.36× | 9.74× | ||
| Q2 25 | 0.35× | 12.14× | ||
| Q1 25 | 0.35× | 16.52× | ||
| Q4 24 | 0.35× | 18.81× | ||
| Q3 24 | 0.35× | 17.75× | ||
| Q2 24 | 0.31× | 60.11× | ||
| Q1 24 | 0.31× | 181.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $388.5M | $141.0M |
| Free Cash FlowOCF − Capex | $233.1M | $96.0M |
| FCF MarginFCF / Revenue | 16.3% | 6.4% |
| Capex IntensityCapex / Revenue | 10.9% | 3.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $692.5M | $538.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $388.5M | $141.0M | ||
| Q3 25 | $355.6M | $264.0M | ||
| Q2 25 | $-7.2M | $220.0M | ||
| Q1 25 | $545.4M | $75.0M | ||
| Q4 24 | $674.0K | $390.0M | ||
| Q3 24 | $240.5M | $141.0M | ||
| Q2 24 | $362.9M | $332.0M | ||
| Q1 24 | $98.0M | $76.0M |
| Q4 25 | $233.1M | $96.0M | ||
| Q3 25 | $223.4M | $218.0M | ||
| Q2 25 | $-126.8M | $181.0M | ||
| Q1 25 | $362.8M | $43.0M | ||
| Q4 24 | $-355.1M | $335.0M | ||
| Q3 24 | $-62.6M | $99.0M | ||
| Q2 24 | $-84.7M | $300.0M | ||
| Q1 24 | $-481.4M | $30.0M |
| Q4 25 | 16.3% | 6.4% | ||
| Q3 25 | 17.1% | 13.6% | ||
| Q2 25 | -9.5% | 11.4% | ||
| Q1 25 | 33.7% | 2.8% | ||
| Q4 24 | -28.8% | 21.0% | ||
| Q3 24 | -4.6% | 6.3% | ||
| Q2 24 | -5.9% | 18.7% | ||
| Q1 24 | -35.4% | 1.8% |
| Q4 25 | 10.9% | 3.0% | ||
| Q3 25 | 10.1% | 2.9% | ||
| Q2 25 | 9.0% | 2.4% | ||
| Q1 25 | 17.0% | 2.1% | ||
| Q4 24 | 28.9% | 3.5% | ||
| Q3 24 | 22.4% | 2.7% | ||
| Q2 24 | 31.3% | 2.0% | ||
| Q1 24 | 42.6% | 2.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.65× | ||
| Q2 25 | -0.31× | 1.52× | ||
| Q1 25 | 13.19× | 0.86× | ||
| Q4 24 | 0.01× | 3.58× | ||
| Q3 24 | — | 0.39× | ||
| Q2 24 | — | 1.70× | ||
| Q1 24 | 40.01× | 0.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALB
| Energy Storage | $759.1M | 53% |
| Specialties | $348.9M | 24% |
| Ketjen | $320.1M | 22% |
OGN
Segment breakdown not available.
